The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
From big data analysis to personalized medicine for all: challenges and opportunities
Open accessAbstract
Recent advances in high-throughput technologies have led to the emergence of systems biology as a holistic science to achieve more precise modeling of complex diseases. Many predict the emergence of personalized medicine in the near future. We are, however, moving from two-tiered health systems to a two-tiered personalized medicine. Omics facilities are restricted to affluent regions, and personalized medicine is likely to widen the growing gap in health systems between high and low-income countries. This is mirrored by an increasing lag between our ability to generate and analyze big data. Several bottlenecks slow-down the transition from conventional to personalized medicine: generation of cost-effective high-throughput data; hybrid education and multidisciplinary teams; data storage and processing; data integration and interpretation; and individual and global economic relevance. This review provides an update of important developments in the analysis of big data and forward strategies to accelerate the global transition to personalized medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Network medicine: a network-based approach to human disease
Barabási, A.-L., Gulbahce, N., & Loscalzo, J. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2918 · Cited by 5,034
Radiomics: the process and the challenges
Kumar, V., Gu, Y., Basu, S., Berglund, A., Eschrich, S. A., Schabath, M. B., Forster, K., Aerts, H. J. W. L., Dekker, A., Fenstermacher, D., et al. (2012) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2012.06.010 · Cited by 2,258 · cited 2×
“integrate, analyze, and interpret omics data [10–12].”
Catalytic activity of the caspase-8–FLIPL complex inhibits RIPK3-dependent necrosis
Oberst, A., Dillon, C. P., Weinlich, R., McCormick, L. L., Fitzgerald, P., Pop, C., Hakem, R., Salvesen, G. S., & Green, D. R. (2011) · Nature · doi:10.1038/nature09852 · Cited by 1,278 · cited 1×
“…has opposing biological functions as it promotes cell death by triggering the extrinsic pathway of apoptosis, while having beneficial effects on cell survival through embryonic development, T-lymphocyte activation, and resistance to necrosis induced by tumor necrosis factor-α (TNF-α ) [68].”
BackgroundHow does multiple testing correction work?
Noble, W. S. (2009) · Nature Biotechnology · doi:10.1038/nbt1209-1135 · Cited by 772
Best Practices for Scientific Computing
Wilson, G., Aruliah, D. A., Brown, C. T., Chue Hong, N. P., Davis, M., Guy, R. T., Haddock, S. H. D., Huff, K. D., Mitchell, I. M., Plumbley, M. D., et al. (2014) · PLoS Biology · doi:10.1371/journal.pbio.1001745 · Cited by 723
Quantitative Image Analysis of Cellular Heterogeneity in Breast Tumors Complements Genomic Profiling
Yuan, Y., Failmezger, H., Rueda, O. M., Ali, H. R., Gräf, S., Chin, S.-F., Schwarz, R. F., Curtis, C., Dunning, M. J., Bardwell, H., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004330 · Cited by 426
Alter, O., Brown, P. O., & Botstein, D. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530258100 · Cited by 304
Comparing Statistical Methods for Constructing Large Scale Gene Networks
Allen, J. D., Xie, Y., Chen, M., Girard, L., & Xiao, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029348 · Cited by 186
Cited by
Deep Learning: Methods and Applications
Deng, L., & Yu, D. (2014) · Foundations and Trends® in Signal Processing · doi:10.1561/2000000039 · Cited by 3,480
Ahmed, Z., Mohamed, K., Zeeshan, S., & Dong, X. (2020) · Database · doi:10.1093/database/baaa010 · Cited by 1,035
Mikalef, P., Boura, M., Lekakos, G., & Krogstie, J. (2019) · British Journal of Management · doi:10.1111/1467-8551.12343 · Cited by 835
Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma
Clark, D. J., Dhanasekaran, S. M., Petralia, F., Pan, J., Song, X., Hu, Y., da Veiga Leprevost, F., Reva, B., Lih, T.-S. M., Chang, H.-Y., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.007 · Cited by 730
Medical big data: promise and challenges
Lee, C. H., & Yoon, H.-J. (2017) · Kidney Research and Clinical Practice · doi:10.23876/j.krcp.2017.36.1.3 · Cited by 594
Metadata
- Authors
- Alyass, A., Turcotte, M., & Meyre, D.
- Venue
- BMC Medical Genomics
- Published
- 2015-06-27
- Volume
- 8
- Issue
- 1
- Pages
- 33-33
- ISSN
- 1755-8794 (ISSN-L)
- OpenAlex
- W1599740911
- Cited by
- 557
- References
- 12
- FWCI
- 22.00
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: From big data analysis to personalized medicine for all: challenges and opportunities. https://app.cochat.ai/papers/10.1186/s12920-015-0108-y
- The paper
- Alyass, A., Turcotte, M., & Meyre, D. (2015). From big data analysis to personalized medicine for all: challenges and opportunities. BMC Medical Genomics. https://doi.org/10.1186/s12920-015-0108-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
